{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:15:39Z","timestamp":1783570539022,"version":"3.55.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003555","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T04:18:13Z","timestamp":1376626693000},"page":"e1003555","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Quantitative Models of the Dose-Response and Time Course of Inhalational Anthrax in Humans"],"prefix":"10.1371","volume":"9","author":[{"given":"Damon J. A.","family":"Toth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi V.","family":"Gundlapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiley A.","family":"Schell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Bulmahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Gallegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Samore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"DA Henderson","year":"1999","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1073\/pnas.0830963100","article-title":"A silent bomb: the risk of anthrax as a weapon of mass destruction","volume":"100","author":"GF Webb","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref3","unstructured":"World Health Organization (2008) Anthrax in Humans and Animals. Geneva: WHO Press. 208 p."},{"key":"ref4","first-page":"872","article-title":"Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(10)60573-9","article-title":"Anthrax infection in drug users","volume":"375","author":"MG Booth","year":"2010","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PHH.0b013e3181ca650d","article-title":"Lessons learned from the investigation of a cluster of cutaneous anthrax cases in Connecticut","volume":"16","author":"A Guh","year":"2010","journal-title":"J Public Health Manag Pract"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"266","author":"M Meselson","year":"1994","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3201\/eid0810.020329","article-title":"Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001","volume":"8","author":"CM Greene","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1073\/pnas.0636861100","article-title":"Emergency response to an anthrax attack","volume":"100","author":"LM Wein","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1287\/mnsc.1040.0348","article-title":"Analyzing bioterror response logistics: The case of anthrax","volume":"51","author":"DL Craft","year":"2005","journal-title":"Management Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1539-6924.2008.01055.x","article-title":"Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax","volume":"28","author":"SS Isukapalli","year":"2008","journal-title":"Risk Anal"},{"key":"ref12","unstructured":"IOM (Institute of Medicine) (2012) Prepositioning antibiotics for anthrax. Washington, DC: National Academies Press. 343 p."},{"key":"ref13","unstructured":"United States Government Accountability Office (2005) Anthrax detection: agencies need to validate sampling activities in order to increase confidence in negative results. Washington, DC: United States Government Accountability Office. 113 p."},{"key":"ref14","unstructured":"United States Government Accountability Office (2012) Anthrax: DHS faces challenges in validating methods for sample collection and analysis. Washington, D.C.: United States Government Accountability Office. 108 p."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1073\/pnas.0509551103","article-title":"Sverdlovsk revisited: modeling human inhalation anthrax","volume":"103","author":"DA Wilkening","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1073\/pnas.102691499","article-title":"Mailborne transmission of anthrax: Modeling and implications","volume":"99","author":"GF Webb","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/153567600701200207","article-title":"Implications of low level human exposure to respirable <italic>B. anthracis<\/italic>","volume":"12","author":"ML Cohen","year":"2007","journal-title":"Applied Biosafety"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/0272-4332.00028","article-title":"On the risk of mortality to primates exposed to anthrax spores","volume":"22","author":"CN Haas","year":"2002","journal-title":"Risk Anal"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1539-6924.2008.01067.x","article-title":"Dose-response models for inhalation of <italic>Bacillus anthracis<\/italic> spores: interspecies comparisons","volume":"28","author":"TA Bartrand","year":"2008","journal-title":"Risk Anal"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/bsp.2007.0066","article-title":"Inhalation anthrax: dose response and risk analysis","volume":"6","author":"ME Coleman","year":"2008","journal-title":"Biosecur Bioterror"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e32732","DOI":"10.1371\/journal.pone.0032732","article-title":"Prioritizing risks and uncertainties from intentional release of selected Category A pathogens","volume":"7","author":"T Hong","year":"2012","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3201\/eid1006.020738","article-title":"Airborne infection with <italic>Bacillus anthracis<\/italic>\u2013from mills to mail","volume":"10","author":"KP Fennelly","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"ref23","first-page":"24","article-title":"<italic>Bacillus anthracis<\/italic> aerosols in goat hair processing mills","volume":"72","author":"CM Dahlgren","year":"1960","journal-title":"Am J Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/MMBR.30.3.646-659.1966","article-title":"Industrial inhalation Anthrax","volume":"30","author":"PS Brachman","year":"1966","journal-title":"Bacteriol Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005","volume":"144","author":"JE Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.30.3.657-659.1966","article-title":"Discussion","volume":"30","author":"HN Glassman","year":"1966","journal-title":"Bacteriol Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1017\/S0022172400015795","article-title":"Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores","volume":"51","author":"HA Druett","year":"1953","journal-title":"J Hyg (Lond)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0043-1354(95)00228-6","article-title":"How to average microbial densities to characterize risk","volume":"30","author":"CN Haas","year":"1996","journal-title":"Water Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jama.1997.03550050061035","article-title":"Clinical recognition and management of patients exposed to biological warfare agents","volume":"278","author":"DR Franz","year":"1997","journal-title":"JAMA"},{"key":"ref30","unstructured":"United States Army Medical Research Institute of Infectious Diseases (2011) USAMRIID&apos;s Medical Management of Biological Casualties Handbook. Washington, DC: US Government Printing Office. 269 p."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5711\/morj.6.3.35","article-title":"Biological warfare human response modeling","volume":"6","author":"GL Rickmeier","year":"2001","journal-title":"Military Operations Research"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/sim.2033","article-title":"Modelling the incubation period of anthrax","volume":"24","author":"R Brookmeyer","year":"2005","journal-title":"Stat Med"},{"key":"ref33","unstructured":"Haas CN, Rose JB, Gerba CP (1999) Quantitative Microbial Risk Assessment. New York: John Wiley and Sons. 464 p."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"DW Henderson","year":"1956","journal-title":"J Hyg (Lond)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1098\/rsif.2010.0491","article-title":"A dynamic dose-response model to account for exposure patterns in risk assessment: a case study in inhalation anthrax","volume":"8","author":"BT Mayer","year":"2011","journal-title":"J R Soc Interface"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.90.6.2291","article-title":"Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979","volume":"90","author":"FA Abramova","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0272989X08315245","article-title":"Modeling the incubation period of inhalational anthrax","volume":"28","author":"DA Wilkening","year":"2008","journal-title":"Med Decis Making"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/biostatistics\/2.2.233","article-title":"The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak","volume":"2","author":"R Brookmeyer","year":"2001","journal-title":"Biostatistics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1073\/pnas.1631983100","article-title":"Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak","volume":"100","author":"R Brookmeyer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref40","first-page":"1008","article-title":"Update: Investigation of bioterrorism-related anthrax, 2001","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1473-3099(04)00940-5","article-title":"Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity","volume":"4","author":"T Fukao","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e1000399","DOI":"10.1371\/journal.pcbi.1000399","article-title":"The effect of ongoing exposure dynamics in dose response relationships","volume":"5","author":"JM Pujol","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mam.2009.06.002","article-title":"Anthrax toxins: a weapon to systematically dismantle the host immune defenses","volume":"30","author":"JN Tournier","year":"2009","journal-title":"Mol Aspects Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3201\/eid0810.020331","article-title":"Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001","volume":"8","author":"MD Jefferds","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/bsp.2011.0005","article-title":"Public response to an anthrax attack: reactions to mass prophylaxis in a scenario involving inhalation anthrax from an unidentified source","volume":"9","author":"G SteelFisher","year":"2011","journal-title":"Biosecur Bioterror"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1128\/AAC.00453-08","article-title":"Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for <italic>Bacillus anthracis<\/italic>?","volume":"52","author":"GL Drusano","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fcimb.2012.00087","article-title":"Inhalational anthrax (Ames aerosol) in naive and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia","volume":"2","author":"BW Gutting","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fcimb.2012.00071","article-title":"Achieving consistent multiple daily low-dose <italic>Bacillus anthracis<\/italic> spore inhalation exposures in the rabbit model","volume":"2","author":"RE Barnewall","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0300985810378112","article-title":"Pathology of inhalational anthrax animal models","volume":"47","author":"NA Twenhafel","year":"2010","journal-title":"Vet Pathol"},{"key":"ref50","unstructured":"R Core Team (2013) R: A Language and Environment for Statistical Computing. Vienna, Austria."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1126\/science.79.2037.38","article-title":"The Method of Probits","volume":"79","author":"CI Bliss","year":"1934","journal-title":"Science"},{"key":"ref52","unstructured":"Finney DJ (1947) Probit Analysis. Cambridge, UK: Cambridge University Press. 272 p."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-2672.2008.03880.x","article-title":"Dose-response model for <italic>Burkholderia pseudomallei<\/italic> (melioidosis)","volume":"105","author":"SB Tamrakar","year":"2008","journal-title":"J Appl Microbiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0042-6822(67)90272-3","article-title":"A mathematical model for the infectivity-dilution curve of tobacco mosaic virus: experimental tests","volume":"32","author":"WA Furumoto","year":"1967","journal-title":"Virology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/0272-4332.204048","article-title":"The Beta Poisson dose-response model is not a single-hit model","volume":"20","author":"PF Teunis","year":"2000","journal-title":"Risk Anal"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/0272989X09340346","article-title":"Recommendations for modeling disaster responses in public health and medicine: a position paper of the society for medical decision making","volume":"29","author":"ML Brandeau","year":"2009","journal-title":"Med Decis Making"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/AEM.01190-10","article-title":"Quantification of the relationship between bacterial kinetics and host response for monkeys exposed to aerosolized <italic>Francisella tularensis<\/italic>","volume":"77","author":"Y Huang","year":"2011","journal-title":"Appl Environ Microbiol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T01:24:50Z","timestamp":1596331490000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003555"}},"subtitle":[],"editor":[{"given":"Claus O.","family":"Wilke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003555","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,15]]}}}